Cisplatin Resistance: Genetic and Epigenetic Factors Involved

Cisplatin Resistance: Genetic and Epigenetic Factors Involved

Cisplatin (CDDP) is the drug of choice against different types of cancer. However, tumor cells can acquire resistance to the damage caused by cisplatin, generating genetic and epigenetic changes that lead to the generation of resistance and the activation of intrinsic resistance mechanisms in cancer...

Full description

Bibliographic Details
Main Authors: Yuliannis Lugones, Pía Loren, Luis A. Salazar
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biomolecules
Subjects:
cancer
cisplatin
drug resistance
epigenetics
Online Access:https://www.mdpi.com/2218-273X/12/10/1365

Similar Items

Similar Items